Summit X, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Summit X, LLC
- $383 Million
- Q1 2024
A detailed history of Summit X, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Summit X, LLC holds 288 shares of REGN stock, worth $310,230. This represents 0.07% of its overall portfolio holdings.
Number of Shares
288
Previous 834
65.47%
Holding current value
$310,230
Previous $732,000
62.16%
% of portfolio
0.07%
Previous 0.21%
Shares
21 transactions
Others Institutions Holding REGN
# of Institutions
1,444Shares Held
82.2MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.62 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$9.23 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.32 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.22 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$5.01 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $115B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...